Ziekenhuis Gelderse Vallei is een van oorsprong christelijk, algemeen ziekenhuis in Ede. Het heeft meer dan 400 bedden en circa 2600 medewerkers. In 2007, 2011 en 2015 is het ziekenhuis geaccrediteerd door het NIAZ.

During the past decade, Ziekenhuis Gelderse Vallei conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 14 clinical trials were completed, i.e. on average, 19.2% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 9 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuis Gelderse Vallei" #1 sponsor was "Radboud University Medical Center" with 15 trials, followed by "The Netherlands Cancer Institute" with 8 trials sponsored, "Wageningen University" with 8 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 6 trials sponsored and "Amsterdam UMC, location VUmc" with 6 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Gelderse Vallei" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 11 trials as a collaborator, "Borstkanker Onderzoek Groep" with 4 trials as a collaborator, "Canisius-Wilhelmina Hospital" with 4 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator and "Gelderse Vallei Hospital" with 3 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuis Gelderse Vallei" are "Heart Failure" (7 trials), "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Cardiovascular Disease" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Ziekenhuis Gelderse Vallei" in a lesser frequency.

Most popular intervention types in "Ziekenhuis Gelderse Vallei" are "Drug" (58 trials), "Other" (20 trials), "Procedure" (10 trials), "Dietary Supplement" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuis Gelderse Vallei" are 97 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Ziekenhuis Gelderse Vallei". undefined are not yet recruiting, 24 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 44 completed trials in Ziekenhuis Gelderse Vallei, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuis Gelderse Vallei, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 27 trials that are defined as “Not Applicable".